Separately, ValuEngine raised shares of Aethlon Medical from a “strong sell” rating to a “sell” rating in a research note on Friday, September 1st.
Aethlon Medical (AEMD) opened at $0.97 on Monday. Aethlon Medical has a one year low of $0.79 and a one year high of $5.17. The company has a debt-to-equity ratio of 78.00, a quick ratio of 2.97 and a current ratio of 2.97.
About Aethlon Medical
Aethlon Medical, Inc is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities.
Receive News & Ratings for Aethlon Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.